Hydroxyapatite formed on/in agarose gel induces activation of blood coagulation and platelets aggregation

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 81, Issue 2, 2007, Pages 456-461

  Arimura, Shin Ichiro ^a   Kawahara, Ko Ichi ^a   Biswas, Kamal Krishna ^a   Abeyama, Kazuhiro ^a   Tabata, Masashi ^b   Shimoda, Toru ^c   Ogomi, Daisuke ^d   Matsusaki, Mchiya ^d   Kato, Shinya ^e   Ito, Takashi ^a   Sugihara, Kazumasa ^a   Akashi, Mitsuru ^d   Hashiguchi, Teruto ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Miyakonojyo Metropolitan Hospital   (Japan)

^c National Sanatorium Hosizukakeiaien   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adsorption; Coagulation; Crystallinity; Hemostatis; Hydroxyl(L)lapatite

Indexed keywords

ADSORPTION; AGGLOMERATION; COAGULATION; CRYSTALLINE MATERIALS; HYDROGELS; X RAY DIFFRACTION;

AGAROSE GELS; BLOOD COAGULATION; HEMOSTATIS; PLATELETS AGGREGATION;

HYDROXYAPATITE;

AGAROSE; HYDROXYAPATITE;

ARTICLE; BLOOD CLOTTING; CRYSTALLIZATION; HEMOSTASIS; HUMAN; HUMAN CELL; POWDER; THROMBOCYTE AGGREGATION; THROMBOPLASTIN TIME; WESTERN BLOTTING; X RAY DIFFRACTION;

ADENOSINE DIPHOSPHATE; ADSORPTION; BLOOD COAGULATION; BONE SUBSTITUTES; DURAPATITE; GELS; HEMOSTASIS; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; POWDERS; PROTHROMBIN TIME; SEPHAROSE; SURFACE PROPERTIES; VITRONECTIN; X-RAY DIFFRACTION;

EID: 34247602938     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30684     Document Type: Article

References (33)

1. Kato K, Aoki H, Tabata T, Ogiso M. Biocompatibility of apatite ceramics in mandibles. Biomater Med Devices Artif Organs 1979;7:291-297.
2. Bell R, Beirne OR. Effect of hydroxylapatite, tricalcium phosphate, and collagen on the healing of defects in the rat mandible. J Oral Maxillofac Surg 1988;46:589-594.
3. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res 1981;157:259-278.
4. Jarcho M. Biomaterial aspects of calcium phosphates. Properties and applications. Dent Clin North Am 1986;30:25-47.
5. Cobb CM, Eick JD, Barker BF, Mosby EL, Hiatt WR. Restoration of mandibular continuity defects using combinations of hydroxylapatite and autogenous bone: Microscopic observations. J Oral Maxillofac Surg 1990;48:268-275.
6. Denissen HW, Kalk W. Preventive implantations. Int Dent J 1991;41:17-24.
7. Byrd HS, Hobar PC, Shewmake K. Augmentation of the craniofacial skeleton with porous hydroxyapatite granules. Plast Reconstr Surg 1993;91:15-22; discussion 23-26.
8. Pettis GY, Kaban LB, Glowacki J. Tissue response to composite ceramic hydroxyapatite/demineralized bone implants. J Oral Maxillofac Surg 1990;48:1068-1074.
9. Bauer G. Biochemical Aspects of Osseointegration. Boston: CRC Press; 1990. pp 81-89.
10. Nagahara K, Isogai M, Shibata K, Meenaghan MA. Osteogenesis of hydroxyapatite and tricalcium phosphate used as a bone substitute. Int J Oral Maxillofac Implants 1992;7:72-79.
11. Meffert RM, Thomas JR, Hamilton KM, Brownstein CN. Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects. J Periodontol 1985;56:63-73.
12. Misch CE, Dietsh F. Bone-grafting materials in implant dentistry. Implant Dent 1993;2:158-167.
13. Wilson J, Low SB. Bioactive ceramics for periodontal treatment: Comparative studies in the Patus monkey. J Appl Biomater 1992;3:123-129.
14. Rao SB, Sharma CP. Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res 1997;34:21-28.
15. Longenecker GL. The Platelets: Physiology and Pharmacoloy. London: Academic Press; 1985.
16. Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun 2003;302:480-483.
17. Tabata M, Shimoda T, Sugihara K, Ogomi D, Serizawa T, Akashi M. Osteoconductive and hemostatic properties of apatite formed on/in agarose gel as a bone-grafting material. J Biomed Mater Res B Appl Biomater 2003;67:680-688.
18. Tabata M, Shimoda T, Sugihara K, Ogomi D, Ohgushi H, Akashi M. Apatite formed on/in agarose gel as a bone-grafting material in the treatment of periodontal infrabony defect. J Biomed Mater Res B Appl Biomater 2005;75:378-386.
19. Taguchi T, Kishida A, Akashi M. Hydroxyapatite formation on/in hydrogels using a novel alternate soaking process. Chem Lett 1998;8:711-712.
20. Taguchi T, Kishida A, Akashi M. Apatite formation on/in hydrogel matrices using an alternate soaking process. II. Effect of swelling ratios of poly(vinyl alcohol) hydrogel matrices on apatite formation. J Biomater Sci Polym Ed 1999;10: 331-339.
21. Taguchi T, Kishida A, Akashi M. Apatite formation on/in hydrogel matrices using an alternate soaking process. III. Effect of physico-chemical factors on apatite formation on/in polyvinyl alcohol) hydrogel matrices. J Biomater Sci Polym Ed 1999;10:795-804.
22. Biswas KK, Sarker KP, Abeyama K, Kawahara K, Iino S, Otsubo Y, Saigo K, Izumi H, Hashiguchi T, Yamakuchi M, Yamaji K, Endo R, Suzuki K, Imaizumi H, Maruyama I. Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. Hepatology 2003;38:1167-1177.
23. Preissner KT, Seiffert D. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 1998;89:1-21.
24. Ginsburg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo RV, Gelehrter TD. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 1986;78:1673-1680.
25. Casaroli Marano RP, Preissner KT, Vilaro S. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp Eye Res 1995;60:5-17.
26. Guettier C, Hinglais N, Bruneval P, Kazatchkine M, Bariety J, Camilleri JP. Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch A Pathol Anat Histopathol 1989;414:309-313.
27. Sato R, Mori M, Imanaka T, Takano T. Accumulation of vitronectin in atherosclerotic lesions where lipids deposited. J Atheroscler Thromb 1994;1(Suppl 1):S50-S54.
28. Jang YC, Arumugam S, Ferguson M, Gibran NS, Isik FF. Changes in matrix composition during the growth and regression of human hemangiomas. J Surg Res 1998;80:9-15.
29. Podor TJ, Campbell S, Chindemi P, Foulon DM, Farrell DH, Walton PD, Weitz JI, Peterson CB. Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and γ A/γ′ fibrinogen. J Biol Chem 2002;277:7520-7528.
30. Asch E, Podack E. Vitronectin binds to activated human platelets and plays a role in platelet aggregation. J Clin Invest 1990;85:1372-1378.
31. Preissner KT. The role of vitronectin as multifunctional regulator in the hemostatic and immune systems. Blut 1989;59:419-431.
32. Jang YC, Tsou R, Gibran NS, Isik FF. Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 2000;127:696-704.
33. Matsusaki M, Kamezawa T, Shimozuru T, Kuratsu J, Kishida A, Akashi M. Novel Guglielmi detachable coils (GDCs) for the treatment of brain aneurysms. In vitro study of hydroxyapatite coating on Pt plate as GDCs model. J Biomed Mater Res B Appl Biomater 2003;66:429-438.